Cancer embryonic antigen (CEA) levels in patients with appendiceal adenocarcinoma predict response to neo-adjuvant chemotherapy and overall survival.

Lena EgbertAbdullah NorainChee-Chee StuckySarwat AhmadYu-Hui ChangNabil Wasif

Published in: Journal of surgical oncology (2022)

In patients with surgically treated appendiceal adenocarcinoma, preoperative elevation in CEA independently predicts decreased 3-year survival and correlates with improved OS with neo-adjuvant therapy. CEA levels should be considered in clinical decision-making regarding neo-adjuvant therapy in patients with appendiceal adenocarcinoma.

Keyphrases

low grade
squamous cell carcinoma
decision making
locally advanced
high grade
papillary thyroid
free survival
patients undergoing
rectal cancer
lymph node metastasis
young adults